《中国药典》2020年版动物类中药功效统计分析和质量评价  

Statistical Analysis and Quality Evaluation of Animal Medicinal Materials in the 2020 Edition of Chinese Pharmacopoeia

作　　者：张恬[1] 袁铭君 李军德[1] ZHANG Tian;YUAN Ming-jun;LI Jun-de(China Academy of Chinese Medical Sciences National Resource Center for Chinese Materia Medica,State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs,Beijing 100700,China)

机构地区：[1]中国中医科学院中药资源中心/道地药材品质保障与资源持续利用全国重点实验室,北京100700

出　　处：《中国现代中药》2023年第8期1627-1634,共8页Modern Chinese Medicine

基　　金：中国中医科学院科技创新工程项目(CI2021A04012);国家自然科学基金项目(82104346)。

摘　　要：动物类中药资源是中药产业发展不可或缺的重要支撑,但和植物类中药相比,其存在资源量不足、药效物质基础不清、缺乏专属质量评价体系等问题。对动物类中药的应用及质量研究现状进行归纳整理,对现存问题进行阐述,针对相关问题提出相应的解决方法。Animal medicinal materials are indispensable support for the development of the traditional Chinese medicine industry.However,compared with plant medicinal materials,animal medicinal materials have some problems,such as insufficient resources,unclear pharmacodynamic material basis,and lack of an exclusive quality evaluation system.In this paper,the application and quality of animal medicinal materials were studied and summarized,and the existing problems of animal medicinal materials were expounded.The relevant problems were analyzed.

关 键 词：动物类中药 资源 质量 

分 类 号：R282[医药卫生—中药学]